Literature DB >> 9829815

Sarcoglycan deficiency in a large Italian population of myopathic patients.

A Prelle1, G P Comi, L Tancredi, C Rigoletto, P Ciscato, F Fortunato, S Nesti, M Sciacco, M Robotti, P Bazzi, G Felisari, M Moggio, G Scarlato.   

Abstract

Autosomal recessive limb-girdle muscular dystrophies are a heterogeneous group of genetic diseases with a wide spectrum of clinical severity and age of onset; mutations in the gene encoding the dystrophin-associated sarcoglycan proteins (alpha, beta, gamma and delta) have recently been shown to cause some cases of these myopathies (primary sarcoglycanopathies, types 2D, 2E, 2C and 2F, respectively). In this study we have examined a large population of Italian myopathic patients to determine the frequency of (alpha-, beta- and gamma-sarcoglycan deficiency and to correlate molecular defects with clinical phenotypes; to exclude the presence of primary dystrophinopathies both genetic and immunological analysis of dystrophin was performed. We report 12 patients (10 male and 2 female) with deficiency of either one or more sarcoglycan proteins. They were aged 8-56 years with onset between 4 and 30 years of age; they all presented with either mild, moderate or severe limb-girdle involvement associated with elevated blood creatine kinase levels and myopathic pattern at EMG; one was also affected with a mild dilation cardiomyopathy. All patients, except one, showed pathological muscle histological changes. Absence of all three proteins always correlates with severe forms, whereas mild protein deficiencies or isolated partial alpha-sarcoglycan deficiency correlate with either severe, moderate or mild forms.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9829815     DOI: 10.1007/s004010050926

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  8 in total

Review 1.  Therapeutic possibilities in the autosomal recessive limb-girdle muscular dystrophies.

Authors:  Volker Straub; Kate Bushby
Journal:  Neurotherapeutics       Date:  2008-10       Impact factor: 7.620

2.  Histologic muscular history in steroid-treated and untreated patients with Duchenne dystrophy.

Authors:  Lorenzo Peverelli; Silvia Testolin; Luisa Villa; Adele D'Amico; Stefania Petrini; Chiara Favero; Francesca Magri; Lucia Morandi; Marina Mora; Tiziana Mongini; Enrico Bertini; Monica Sciacco; Giacomo P Comi; Maurizio Moggio
Journal:  Neurology       Date:  2015-10-23       Impact factor: 9.910

3.  Genotype and phenotype characterization in a large dystrophinopathic cohort with extended follow-up.

Authors:  Francesca Magri; Alessandra Govoni; Maria Grazia D'Angelo; Roberto Del Bo; Serena Ghezzi; Gandossini Sandra; Anna Carla Turconi; Monica Sciacco; Patrizia Ciscato; Andreina Bordoni; Silvana Tedeschi; Francesco Fortunato; Valeria Lucchini; Sara Bonato; Costanza Lamperti; Domenico Coviello; Yvan Torrente; Stefania Corti; Maurizio Moggio; Nereo Bresolin; Giacomo Pietro Comi
Journal:  J Neurol       Date:  2011-03-12       Impact factor: 4.849

4.  Frequency and characterisation of anoctamin 5 mutations in a cohort of Italian limb-girdle muscular dystrophy patients.

Authors:  Francesca Magri; Roberto Del Bo; Maria Grazia D'Angelo; Monica Sciacco; Sandra Gandossini; Alessandra Govoni; Laura Napoli; Patrizia Ciscato; Francesco Fortunato; Erika Brighina; Sara Bonato; Andreina Bordoni; Valeria Lucchini; Stefania Corti; Maurizio Moggio; Nereo Bresolin; Giacomo Pietro Comi
Journal:  Neuromuscul Disord       Date:  2012-06-27       Impact factor: 4.296

5.  Clinical and molecular characterization of a cohort of patients with novel nucleotide alterations of the Dystrophin gene detected by direct sequencing.

Authors:  Francesca Magri; Roberto Del Bo; Maria G D'Angelo; Alessandra Govoni; Serena Ghezzi; Sandra Gandossini; Monica Sciacco; Patrizia Ciscato; Andreina Bordoni; Silvana Tedeschi; Francesco Fortunato; Valeria Lucchini; Matteo Cereda; Stefania Corti; Maurizio Moggio; Nereo Bresolin; Giacomo P Comi
Journal:  BMC Med Genet       Date:  2011-03-11       Impact factor: 2.103

6.  MYH2 myopathy, a new case expands the clinical and pathological spectrum of the recessive form.

Authors:  Roberta Telese; Serena Pagliarani; Alberto Lerario; Patrizia Ciscato; Gigliola Fagiolari; Denise Cassandrini; Nadia Grimoldi; Giorgio Conte; Claudia Cinnante; Filippo M Santorelli; Giacomo P Comi; Monica Sciacco; Lorenzo Peverelli
Journal:  Mol Genet Genomic Med       Date:  2020-06-24       Impact factor: 2.183

7.  Progression to Loss of Ambulation Among Patients with Autosomal Recessive Limb-girdle Muscular Dystrophy: A Systematic Review.

Authors:  Ivana F Audhya; Antoinette Cheung; Shelagh M Szabo; Emma Flint; Conrad C Weihl; Katherine L Gooch
Journal:  J Neuromuscul Dis       Date:  2022

8.  Antisense Morpholino-Based In Vitro Correction of a Pseudoexon-Generating Variant in the SGCB Gene.

Authors:  Francesca Magri; Simona Zanotti; Sabrina Salani; Francesco Fortunato; Patrizia Ciscato; Simonetta Gerevini; Lorenzo Maggi; Monica Sciacco; Maurizio Moggio; Stefania Corti; Nereo Bresolin; Giacomo Pietro Comi; Dario Ronchi
Journal:  Int J Mol Sci       Date:  2022-08-29       Impact factor: 6.208

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.